Company Intelligence Profile
Esente Healthcare Private Limited
Esente Healthcare is a nuclear medicine and molecular imaging company working on affordable cancer diagnosis and therapy.
Last updated 26 October 2026
Esente Healthcare Private Limited is a nuclear medicine and molecular imaging company focused on cancer diagnosis and therapy. It offers radiopharmaceuticals, cold kits for PET and SPECT imaging, quality-control equipment and imaging software. The company was incorporated on 23 December 2014 in Karnataka and is based in Bangalore. The Federal Bank Limited holds 5 charges on the company totalling about ₹0.7 Cr.
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
See what AICA knows about Esente Healthcare
Deeper analysis, financial signals and peer comparisons.
Company Identity
| Registered name | ESENTE HEALTHCARE PRIVATE LIMITED |
|---|---|
| CIN | U24230KA2014PTC077890 |
| Status | Active |
| Listing | Unlisted |
| Incorporated | 23 December 2014 |
| ROC | RoC Karnataka |
| Sector (NIC) | Pharma & Life Sciences |
| Registered address | Conflicting addresses across |
| Authorized capital | INR 1,25,00,000 (Rs. 1.25 crore) - |
| Paid-up capital | INR 1,23,20,000 (Rs. 1.232 crore) - |
Source: www.tofler.in
Business Overview
- Esente Healthcare works in nuclear medicine and molecular imaging for cancer diagnosis and therapy.
- It offers radiopharmaceuticals and cold kits for PET and SPECT imaging and targeted therapy.
- It also offers quality-control equipment, imaging software, cyclotron accessories and radiation safety products.
- The company is based in Bommasandra Industrial Area, Bangalore, and was incorporated on 23 December 2014.
Source: www.tofler.in
Directors
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Muraleedharan Ajithkumar | 05309579 | Director | 21 Sep 2020 |
| Prathap Madhavan Pillai | 08912498 | Director | 21 Sep 2020 |
| Arackal Nelliserry Antony Varghese | 06992194 | Director | 23 Dec 2014 |
| Afsal Mohammed Kadavilpparampu Mohamed | 07005327 | Director | 23 Dec 2014 |
Source: www.tofler.in
Charges & Borrowings
- The Federal Bank Limited holds 5 charges totalling about ₹0.7 Cr.
- The charges were created between 29 Sep 2018 and 22 Jun 2022.
Source: www.tofler.in
Competitors
Frequently Asked Questions
What does ESENTE HEALTHCARE PRIVATE LIMITED do?
Who are the directors of ESENTE HEALTHCARE PRIVATE LIMITED?
When was ESENTE HEALTHCARE PRIVATE LIMITED incorporated?
What is the CIN of ESENTE HEALTHCARE PRIVATE LIMITED?
Where is ESENTE HEALTHCARE PRIVATE LIMITED registered?
Recur Market
Which lenders fit a company like Esente Healthcare Private Limited?
Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.
Similar Pharma & Life Sciences companies
- DIVINECARE PHARMA PRIVATE LIMITEDDIVINECARE PHARMA PRIVATE LIMITED is a private company in Bengaluru, classed as a pharmaceutical manufacturer, incorporated in June 2020.
- ICON Clinical Research India Private LimitedICON Clinical Research India is the Indian arm of global research firm ICON plc, running clinical trials for drug, biotech and medical-device companies.
- Scitus Pharma Services Private LimitedScitus Pharma Services Private Limited is a Chennai-based private company classified under scientific research and development services.
- VIMAL DRUGS PRIVATE LIMITEDVIMAL DRUGS PRIVATE LIMITED makes bulk drugs and intermediates from its base in Hyderabad, Telangana.
- SIA PHARMA PRIVATE LIMITEDSIA PHARMA PRIVATE LIMITED is a pharmaceutical company based in Sonipat, Haryana, incorporated in 2008.
- Fermedicius Labs Private LimitedFermedicius Labs contract-manufactures nutraceuticals, herbal products and wellness supplements, with private-label options, from Bengaluru.
More on Recur Club
Recently added companies
Lenders on Recur Club
Explore on Recur Club
More from Recur Club
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.